Merus to Participate in William Blair’s Biotech Focus Conference 2021

NEXT STORY
OpGen Announces Partial Adjournment of Annual Meeting
PREV STORY
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Five Prime Therapeutics Presents Poster on FGFR2b Expression and Immune Signature in Urothelial Cancer at the Society for Immunotherapy of Cancer 32nd Annual Meeting

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), ...

author_avatar
NASDAQ Market News

ContraFect to Present at 10th Annual Biotech Showcase

YONKERS, N.Y., Jan. 03, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...

author_avatar
NASDAQ Market News

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

Expanding global oncology testing for clinical trials WILMINGTON, N.C., June 01, 2018 (GLOBE NEWSWIRE) ...

author_avatar
NASDAQ Market News